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Summary  Dengue  fever  is  a  vector-borne  disease  that  is  transmitted  to  humans
by  infected  Aedes  aegypti  mosquitoes.  The  eastern  part  of  the  Sudan  is  one  of
the  regions  that  is  affected  by  dengue  virus  circulation.  In  this  study,  we  esti-
mated  the  prevalence  of  dengue  infections  in  the  Kassala  state  in  the  eastern
part  of  the  Sudan.  The  study  objective  was  to  estimate  the  sero-prevalence  of
dengue  IgG/IgM  antibodies  in  the  Kassala  locality  in  2011.  This  was  a  cross  sec-
tional  community-based  study  that  utilized  a  multi-stage  cluster  sampling  technique
regarding  the  probability  sampling  the  study  participants.  Capture  ELISA  serologi-
cal  techniques  were  used  for  both  IgM  and  IgG,  with  the  speciﬁc  cut-offs  for  each
set  by  the  manufacturer.  The  prevalence  of  dengue  infection  was  found  to  be  9.4%
(95%  CI:  7.1—12.3).  In  conclusion,  there  is  evidence  that  the  dengue  virus  is  being
∗ Corresponding author at: Sudan Federal Ministry of Health, Nile Street, Khartoum, Sudan. Tel.: +249 912387175.
E-mail address: Soghaier@gmail.com (M.A. Soghaier).
1 Current address: Supreme Council of Health, Qatar.
2 Current address: Biogen Idec, Cambridge, MA, USA.
ttp://dx.doi.org/10.1016/j.jiph.2015.04.023
876-0341/© 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
488  
transmitted  in  Kassala.  Dise
entomological  components,  
studies  are  needed  to  better  
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Introduction
Dengue  is  a  vector-borne  virus  that  is  most  com-
monly transmitted  to  humans  by  infected  Aedes
aegypti mosquitoes.  Dengue  is  a  disease  of  tropical
and sub-tropical  areas  [1,2]. Due  to  the  prefer-
ence of  the  mosquitoes  for  peri-domestic  breeding
sites,  the  dengue  burden  has  been  increasing  as
the populations  of  tropical  cities  have  increased
and has  consequently  become  a  public  health  prob-
lem of  global  importance.  The  dengue  virus  is
now endemic  in  more  than  100  countries,  and  it
has recently  been  estimated  that  approximately
390 million  (95%  conﬁdence  interval  284—528)
dengue infections  occur  annually  and  that  96  mil-
lion (67—136)  of  those  infections  are  symptomatic
with any  level  of  disease  severity  [1,3,4]. Urban-
ization,  climate  changes,  ease  of  movement  and
travel and  other  biological  factors  have  facilitated
the geographic  expansion  of  A.  aegypti  mosquitoes
and the  spread  and  co-circulation  of  different
viral serotypes  [5].  Dengue  virus  has  4 identi-
ﬁed serotypes  [6]. The  initial  infection  is  usually
referred to  as  a  primary  infection,  and  re-infection
with another  serotype  is  known  as  a secondary
infection. Primary  infections  result  in  the  clinical
syndrome  of  dengue  fever  (DF),  which  is  almost
always self-limited  [7].  During  the  primary  infec-
tion,  dengue  fever  is  characterized  by  an  increase
in speciﬁc  IgM  antibodies  3—5  days  after  the  onset
of symptoms  and  may  persist  as  long  as  30—90
days. IgG  antibodies  usually  appear  after  approx-
imately two  weeks  of  infection  and  may  persist  for
life. During  a  second  or  subsequent  infection,  the
immune  response  is  characterized  by  an  increase
in IgG  within  1—2  days  of  the  onset  of  symptoms,
whereas IgM  antibodies  are  induced  later  [8,9].
The co-circulation  of  different  dengue  serotypes
in a  single  place  is  deﬁned  as  hyperendemicity
and  is  a  predisposing  factor  for  more  severe  forms
of disease  presentation,  including  dengue  hemor-
rhagic  fever  (DHF)  and  dengue  shock  syndrome
(DSS).
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ase  surveillance,  including  the  clinical,  serological  and
should  be  strengthened,  and  additional  epidemiological
understand  of  the  disease  burden  and  effects  in  the  area.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
The  Kassala  state  in  the  eastern  part  of  the
udan has  witnessed  increasing  numbers  of  dengue
utbreaks  in  the  last  few  years.  Some  patients
ave presented  with  severe  forms  of  the  disease,
nd mortalities  have  also  been  reported  [10].  The
evere forms  of  the  disease  place  a  large  burden
n the  health  facilities  in  Kassala  because  of  the
eed for  sophisticated  medical  care  and  expertise.
t is expected  that  the  dengue  problem  in  Kassala
ill persist  for  the  foreseeable  future  because  the
ity is  growing  and  because  connections  with  Port
udan (a  known  endemic  dengue  area  of  the  Red
ea coast)  exist.  It  is  assumed  that  more  than  one
engue  virus  serotype  is  currently  circulating  in
assala because  of  the  disease  severity  in  recent
ears  and  the  conﬁrmation  of  the  co-circulation  of
engue serotypes  in  the  Red  Sea  region  close  to  Kas-
ala; however,  this  requires  further  conﬁrmation  in
he future  [11]. It  is  initially  important  to  conduct
opulation-based  prevalence  surveys  to  determine
he proportion  of  asymptomatic  cases  in  Kassala
ecause  data  on  the  actual  burden  of  the  disease
re crucial  for  public  health  authorities  to  plan  con-
rol programs.  This  study  was  mandated  to  estimate
he sero-prevalence  of  dengue  infections  in  Kassala
n 2011.
ethodology
tudy design
 cross  sectional  community-based  study  design
as applied  in  the  Kassala  state  in  the  eastern
art of  Sudan.  This  state  is  bordered  by  Eritrea  and
thiopia to  the  east,  the  Red  Sea  state  to  the  north,
hartoum  and  the  River  Nile  states  to  the  west
nd the  Gadarif  state  to  the  south  west.  Its  land
2pace is  42,282  km . The  local  Kassala  population  is
98,529 people  living  in  97  neighborhoods,  and  the
otal number  of  household  is  52,853  according  to
he 2008  census.
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This  community-based  survey  was  conducted  in
he total  population  of  the  Kassala  locality.  Partic-
pants  of  both  genders  over  the  age  of  5  years  who
rovided written  informed  consent  were  included
n the  study.  Participants  <18  years  of  age  were
equired to  obtain  written  consent  from  a  parent
efore  providing  their  own.  Participants  who
esided in  Kassala  for  the  previous  6 months  were
xcluded.  A  multi-stage  cluster  sampling  technique
as  used  to  select  the  study  participants  [12].  In
he ﬁrst  stage,  the  clusters  (which  were  equivalent
o a  Popular  Administrative  Units  (PAUs))  were
elected  using  the  probability  proportionate  to  size
echnique  (PPS)  [13]. In  the  second  stage,  house-
olds  were  selected  using  a  systematic  random
ampling technique.  Within  each  household,  simple
andom  sampling  was  used  to  select  one  partici-
ant from  among  the  eligible  population  who  were
resent  at  the  time  of  the  data  collector’s  visit.
ample size
he  calculated  sample  required  to  provide  an  esti-
ate of  the  prevalence  of  dengue  antibodies  at the
5% conﬁdence  level  was  530.  A  design  effect  of  2
nd a  non-response  rate  of  10%  were  considered  to
djust for  the  sampling  technique.  The  formula  for
he calculation  of  the  sample  size  was  applied  with
penEpi  software  [14].
ata collection
ersonal  and  clinical  data  were  collected  using
 structured  and  standardized  questionnaire.
he questionnaires  were  administered  by  well-
rained community  health  volunteers.  Additionally,
 venous  blood  sample  was  collected  from  each
ubject for  laboratory  testing  and  outcome  estima-
ion.  These  blood  samples  were  collected  by  senior
hlebotomists  from  the  state  national  public  health
aboratory.
aboratory analysis and outcome
etermination
engue  can  occur  as  a  primary  or  secondary
nfection,  and  each  of  these  infection  types  is  char-
cterized  by  a  speciﬁc  immunologic  response.  In
his analysis,  both  dengue  IgG  and  IgM  antibodies
ere tested  in  each  participant,  and  the  sero-
revalence was  estimated.  The  blood  samples  were
nalyzed  using  Panbio  ELISA  kits  (DF  IgG  and  IgM
apture)  [15].  Positive  and  negative  control  serum
pecimens  were  used,  and  the  ELISA  kits  were
ested before  the  serum  samples  were  analyzed.
i
e
o
Irt  of  the  Sudan  489
he  test  has  a high  sensitivity  (99.72%)  and  speci-
city (99.62%).  Each  test  kit  contains  a  calibrator
nd positive  and  negative  controls.  The  average
bsorbance of  the  triplicates  of  the  calibrator  were
alculated  and  multiplied  by  the  calibration  factor
o obtain  the  cut-off  value  [15,16]. All  of  the  sero-
ogical tests  were  conducted  at  the  Sudan  National
ublic  Health  Laboratory  within  the  Federal  Min-
stry of  Health  in  Khartoum,  which  has  considerable
xperience in  the  detection  and  conﬁrmation  of
rboviruses  and  has  a continuous  program  for  vali-
ation and  quality  control.
thical considerations
thical  approval  was  granted  by  the  ethical  review
ommittee of  the  Kassala  State  Ministry  of  Health
efore  the  start  of  the  study.  Written  informed
onsent was  obtained  from  all  survey  participants.
articipants <18  years  of  age  were  required  to
btain written  consent  from  a parent  before  pro-
iding their  own.  Participation  in  the  survey  was
oluntary,  and  no  gifts  or  ﬁnancial  incentives  were
ffered.
esult
ive  hundred  individuals  were  asked  to  partici-
ate in  this  survey;  491  (90.9%)  enrolled  and  were
ncluded  in  the  analysis.  Analyzable  blood  samples
nd results  were  available  for  only  489  participants.
he study  population  was  60%  female  and  40%  male.
ore than  60%  of  the  population  had  no  more  than
 primary  education  and  some  had  only  received
n informal  education  or  no  education  at  all.  The
ain characteristics  of  the  study  participants  are
resented  in  Table  1.
All 489  samples  were  tested  for  both  IgG  and
gM using  capture  ELISA  techniques.  The  prevalence
f IgG  in  Kassala  was  found  to  be  9.4%  (95%  CI:
.1—12.3).  Positive  IgM  capture  ELISA  results  indi-
ate the  presence  of  a  recent  dengue  infection
nd were  detected  in  only  3  samples  (0.6%,  95%
I: 0.13—1.8).  Table  2  provides  a  summary  of  the
aboratory  tests  results.
Children  aged  5—14  years  old  were  found  to  be
he most  affected  group.  There  were  3  participants
n this  age  group,  and  one  of  them  was  positive;
owever, we  cannot  draw  conclusions  about  this
esult due  to  the  small  representation  of  this  group
n the  study  sample.  The  35—44-year-old  age  group
xhibited  a  prevalence  of  12%  and  the  25—34-year-
ld age  group  exhibited  a 10.7%  prevalence  of  the
gM dengue  antibody.  The  results  of  the  analyses
490  S.  Himatt  et  al.
Table  1  Main  individual  characteristics  of  study  par-
ticipants,  Kassala  2011.
Characteristics  Frequency  Percent  (%)
Result  of  the  HH  interview  (n  =  540)
Completed  491  90.9
Refuse 49  9.1
Age  groups  (n  =  524)
<25  years 106  20.2
25—35  years 193  36.8
36—45  years  100  19.1
>45  years  125  23.9
Mean  age  (95%  CI)  36.59  (35.39—37.79)
Age  Max—Min  (SD)  13—85  (14)
Sex  of  the  interviewee  (n  =  525)
Male  210  40.0
Female  315  60.0
Highest  level  of  school  (n  =  493)
Never  attended  school  88  17.8
Informal  education  59  12.0
Primary  school  162  32.9
Intermediate  school 31  6.3
Secondary  school 107  21.7
College/certiﬁcate  42  8.5
Higher  education 4  .8
Relation  of  the  respondent  to  household  head  (n  =  528)
Household  head 147  27.8
Husband/wife  195  36.9
Son/daughter  130  24.6
Father/mother  20  3.8
Table  3  Seo-prevalence  of  dengue  IgM  antibody  by
age  group,  Kassala  locality  2011.
Age  group
in  years
No.  positive/
no.  tested
Dengue
sero-prevalence  (%)
5—14  1/3  33.3
15—24  8/96  8.3
25—34 16/150  10.7
35—44 12/100  12
45—54 7/79  8.9
55—64 2/38  5.3
65—74  0/17  0
75  or  more  0/2  0
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ﬁBrother/sister  18  3.4
Others  18  3.4
of  the  dengue  sero-prevalence  by  age  group  are
presented in  Table  3.
Discussion
The  prevalence  of  dengue  IgG  in  Kassala  was  found
to be  9.4%  (95%  CI:  7.1—12.3),  whereas  the  preva-
lence of  IgM  was  0.6%  (95%  CI:  0.13—1.8),  which
was equivalent  to  3 positive  samples  among  the
survey participants,  and  IgM  is  an  indicator  of  a
recent dengue  infection  [8,9].  A  recent  study  con-
ducted in  the  southern  part  of  the  Sudan  estimated
f
s
K
w
Table  2  Capture  ELISA  test  results  of  IgG  and  IgM  for  deng
ELISA  result  Frequency  
Dengue  IgG  capture  ELISA  (N  =  489)
Positive  46  
Negative  443  
Dengue  IgM  capture  ELISA  (N  =  489)
Positive 3  
Negative  486  he  overall  prevalence  of  dengue  to  be  27.7%  (95%
I: 24.1—31.3%),  although  the  general  assumption
s that  the  prevalence  in  Kassala  might  be  greater
han currently  estimated.  This  could  be  consid-
red to  be  one  of  the  study’s  limitations  because
gG levels  occasionally  wane  below  the  IgG  ELISA
ut-off, which  leads  to  misses  (both  primary  and
econdary)  several  years  after  exposure.  Monotypic
nd polytypic  PRNT  responses  can  be  assessed  in
he future  to  more  accurately  estimate  the  overall
revalence [17]. In  this  study,  5—14-year-old  chil-
ren were  found  to  be  the  age  group  that  was  most
ffected  by  dengue  (prevalence:  33.3%).  Although
o conclusions  can  be  drawn  regarding  this  result
ue  to  the  small  sample  size  of  this  age  group,  this
esult is still  suggestive  that  infection  among  young
hildren  might  be  associated  with  severe  clinical
resentations, such  as  DHF,  which  was  noted  dur-
ng recent  dengue  outbreaks  in  the  eastern  region
f Sudan  [18,19]. Given  the  currently  available
irological and  entomological  knowledge,  the  high
edes mosquito  densities  in  this  region  and  the
ocumented circulation  of  more  than  two  dengue
erotypes in  the  neighboring  Red  Sea  coasts,  our
ndings  are  further  suggestive  of  an  increased  risk
or the  development  of  more  severe  clinical  pre-
entations  of  the  disease  in  the  near  future  in
assala  [20—22]. In  terms  of  the  estimated  IgM,
hich is  indicative  of a  recent  dengue  infection,
ue  sero-prevalence  survey  in  Kassala  locality  2011.
Percent  95%  conﬁdence  interval
9.4  6.8—12.0
90.6  88.0—93.1
0.6  0.13—1.8
99.4  98.2—99.8
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[engue  infections  in  the  Kassala  state  in  the  easter
he  prevalence  among  the  study  participants  was
pproximately  0.6%,  but  this  ﬁgure  might  have  been
nderestimated  because  the  survey  was  conducted
n the  low  transmission  season,  as  shown  in  another
tudy  conducted  in  the  neighboring  Red  Sea  state
21].
Although  this  is  the  ﬁrst  study  to  report  the
ero-prevalence  of  dengue  in  Kassala,  it  has
ome limitations  that  should  be  addressed  in  the
uture.  Studies  of  cumulative  dengue  infection  with
ore sophisticated  methodologies  are  expected
o provide  more  precise  estimates  of  the  magni-
ude of  the  disease  burden.  Additionally,  identifying
engue  virus  serotypes  that  are  circulating  in  Kas-
ala is an  important  task  that  has  to  be  performed
n subsequent  studies.
onclusion
he  dengue  sero-prevalence  is  9.4%  in  Kassala.
he disease  surveillance  system,  including  its  clin-
cal, serological  and  entomological  dimensions,
hould be  strengthened.  Medical  treatment  capac-
ties should  be  created  to  deal  with  the  probable
evelopment of  more  severe  clinical  presentations
f dengue  in  Kassala.  Proper  vector  control  inter-
entions  and  community  awareness/participation
hould  be  adopted  to  interrupt  the  disease  trans-
ission  cycle.
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